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Abstract  
Muscle bulk in adult healthy humans is highly variable even after accounting for height, age and 
sex. Low muscle mass, due to fewer and/or smaller constituent muscle fibers, would exacerbate 
the impact of muscle loss occurring in aging or disease. Genetic variability substantially influences 
muscle mass differences, but causative genes remain largely unknown. In a genome-wide 
association study (GWAS) on appendicular lean mass (ALM) in a population of 85,750 middle-age 
(38-49 years) individuals from the UK Biobank (UKB) we found 182 loci associated with ALM 
(P<5x10-8). We replicated associations for 78% of these loci (P<5x10-8) with ALM in a population of 
181,862 elderly (60-74 years) individuals from UKB. We also conducted a GWAS on hindlimb 
skeletal muscle mass of 1,867 mice from an advanced intercross between two inbred strains (LG/J 
and SM/J) which identified 23 quantitative trait loci. 38 positional candidates distributed across 5 
loci overlapped between the two species. In vitro studies of positional candidates confirmed 
CPNE1 and STC2 as modifiers of myogenesis. Collectively, these findings shed light on the 
genetics of muscle mass variability in humans and identify targets for the development of 
interventions for treatment of muscle loss. The overlapping results between humans and the 
mouse model GWAS point to shared genetic mechanisms across species.  
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Introduction 
Skeletal muscle plays key roles in locomotion, respiration, thermoregulation, maintenance 
of glucose homeostasis and protection of bones and viscera. The loss of muscle due to aging, 
known as sarcopenia, affects mobility and can lead to frailty and deterioration of quality of life1. The 
risk of disability is 1.5 to 4.6 times higher in the sarcopenic elderly than in the age-matched 
individuals with normal muscle mass2. However, lean mass, a non-invasive proxy for muscle mass, 
differs by more than two-fold between healthy adult individuals of same sex, age and height3. 
Therefore, we hypothesize that differential accretion of muscle mass by adulthood may influence 
the risk of sarcopenia and frailty later in life. 
Genetic factors contribute substantially to the variability in lean mass in humans, with 
heritability estimates of 40 – 80 %4. A continuous distribution of the trait and data obtained from 
animal models5-8 indicates a polygenic causality. However, thus far, genome-wide association 
studies (GWAS) have implicated fewer than a dozen genes, explaining a small fraction of this 
heritability9; 10. Limited sample size in early studies11-15 and the effects of confounders such as 
subject age9, size of the skeleton and lean mass components (non-fat organs and tissues, 
heterogeneity of muscle fibers) have hindered detection of genes. The UK Biobank is a resource of 
demographic, phenotypic and genotypic data collected on ~500,000 individuals16. It includes the 
arm and leg lean mass, body composition and morphometric information, providing a model for 
improving our understanding of the genetic basis for variability in muscle mass. Skeletal muscle 
mass, however, changes over the course of an individual’s lifespan. It reaches a peak around mid-
twenties and remains largely stable through mid-forties, before succumbing to gradual decline, 
which accelerates after about 70 years of age17. There is a substantial degree of individual 
variability in the slope of muscle change across both the increasing and decreasing phases of the 
lifespan trajectory18. Both the trajectory itself and the slope of individual variability may impede 
identification of genes. 
The indirect estimates of lean mass impose limitations because muscle mass is not an 
exclusive contributor to this variable. Furthermore, the cellular basis of variability in muscle mass 
(i.e. if it is caused by the differences in the number of constituent muscle fibers, their size, or both) 
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remains poorly understood. Using the laboratory mouse circumvents a number of those limitations. 
The mouse shares approximately 90% of the genome with humans19, and dissection permits 
analyses of traits that are difficult to study directly in humans, such as the mass of individual 
muscles 6; 7; 20 and whole-muscle fiber characteristics21; 22. The phenotypic differences between the 
LG/J and SM/J mouse strains make them particularly attractive for complex trait analyses23-25. LG/J 
mice were selected for large body size26, while SM/J mice were selected for small body size27. The 
second filial generation (F2) of intercross derived from the LG/J and SM/J strains (LGSM)6; 28 and 
an advanced intercross line (AIL) of the LGSM (LGSM AIL), developed using a breeding strategy 
proposed by Darvasi and Soller29, led to multiple quantitative trait loci (QTLs) for hindlimb muscle 
mass6; 28. However, these QTLs still encompass tens or even hundreds of genes and require 
further prioritizing. We hypothesized that the detection power of a modest sample size of the 
LGSM AIL and the superior resolution of a human cohort will facilitate identification of the 
quantitative trait genes (QTGs) underlying muscle QTLs. 
The aim of this study was to identify the genomic loci and the underlying genes for 
variability in skeletal muscle mass and to assess their effects in the elderly. We addressed this in 
three stages: (1) we conducted a GWAS in a human cohort of middle-aged individuals from the UK 
Biobank and tested the effect of the identified set of loci in an elderly cohort; (2) we conducted a 
GWAS on hindlimb muscle mass in a population of LGSM AIL mice. (3) In the final stage, we 
nominated candidate genes by comparing mouse and human loci and validated the myogenic role 
of selected candidates in vitro. 
 
Methods 
Stage one: Genome mapping in human populations 
UK Biobank cohort 
The population in this study consisted of 316,589 adult individuals of 37 to 74 years of age (project 
ID: 26746). We drew this cohort from the UK Biobank (UKB) project16; all participants recruited 
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were identified from the UK National Health Service (NHS) records and attended a baseline visit 
assessment between 2006 and 2010. During the assessment, participants gave written consent, 
answered a questionnaire, and were interviewed about their health and lifestyle. Blood samples 
and anthropometric measurements were collected from each participant. Assessments were 
conducted at 22 facilities in Scotland, England, and Wales. 
We divided the sample into middle-aged and elderly cohorts. The middle-aged cohort 
consisted of 99,065 adults ranging from 38 to 49 years of age; based on previous studies we 
assumed that these individuals were not affected by sarcopenia30. We excluded 3,520 participants 
that were reported to be ill with cancer, pregnant, or had undergone a leg amputation procedure, 
as well as individuals with discordant genetic sex and self-reported sex records. In addition, we 
excluded non-white Europeans (self-reported) from the analyses (n = 9,599) and individuals 
without imputed genotypes. We retained a total of 85,750 adult individuals (46,353 females and 
39,397 males) for further analyses.  
The elderly cohort consisted of 217,524 adults ranging from 60 to 74 years of age. We 
selected this cohort to test if the effect of the genetic variants identified on middle-aged individuals 
could also influenced phenotypes later in life. We excluded 35,662 individuals based on the same 
criteria used for the middle-aged cohort. After exclusions, the elderly cohort included 181,862 
individuals of 60 to 73 years of age (94,229 females and 87,633 males; Table S1). 
UK biobank traits 
We used the data for standing height (UKB field ID: 50), sitting height (UKB field ID: 20015), whole 
body fat (UKB field ID: 23100), arm lean mass (UKB field ID: 23121 and 23125), and leg lean mass 
(UKB field ID: 23113 and 23117) measured as part of the UK Biobank project. Body composition 
measurements were taken using bioelectric impedance (this was preferred to the DXA scan data 
because of the substantially larger number of phenotyped individuals). We calculated leg length by 
subtracting sitting height from standing height (all measurements were recorded in cm). Because 
lean mass in the limbs primarily consists of skeletal muscle tissue, we used ALM as a proxy for 
muscle mass. We calculated ALM as the sum of the muscle mass of two arms and two legs. We 
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checked that all traits were normally distributed by examining the QQ-plot and histogram of 
residuals from a simple linear model that included sex as a covariate. Residuals were normally 
distributed, and we did not transform any of the traits.  
 
UK biobank genotypes 
We obtained genotype data for all participants from the UKB v3 genotypes release31, which 
includes genotype calls from the Affymetrix UK BiLEVE Axiom array and the Affymetrix UK 
Biobank Axiom array, and imputed genotypes from the UK10K and 1000 Genomes Phase 3 
reference panels32. We kept all imputed genotype data (21,375,087 genetic variants (SNPs, Indels 
and structural variants)) with MAF > 0.001 and imputation quality > 0.30. The software (BOLT-LMM 
v2.3.4) 33 we used to perform GWAS was developed for large data sets (i.e.: UK Biobank cohort) 
and it was only tested for human cohorts, which have different LD patterns from animals; BOLT-
LMM uses a linear mixed model, which have been shown to successfully control for confounding 
due to population structure or cryptic relatedness in individuals (related and unrelated) from the UK 
biobank34-37. For these reasons, we used BOLT-LMM v2.3.4 for the analyses of human data only.  
 
Appendicular lean mass GWAS 
We used BOLT-LMM (v2.3.4)38 to perform a GWAS for ALM in the middle-aged cohort. The linear 
mixed model (LMM) approach implemented in BOLT-LMM is capable of analyzing large data sets 
while also accounting for cryptic relatedness between individuals. Specifically, BOLT-LMM 
calibrates the association statistics using a linkage disequilibrium (LD) score regression 
approach39; this allowed us to evaluate the impact of confounding factors on the GWAS test 
statistics39 and calibrate them accordingly. In the absence of confounding factors, P values should 
not be inflated, and the LD score regression intercept should be equal to 139. The LD Score 
regression intercept in this study was 1.051 ± 0.007, suggesting minimal inflation of P values due 
to linkage between markers. After calibrating the test statistics, the mean 2 of the ALM GWAS 
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was 1.29 and lambda (λGC) or genomic control inflation factor was 1.20 (Figure S1), which 
indicated polygenicity of the trait as described by Bulik-Sullivan and colleagues39.  
We also assessed population structure by running principal component analysis on the 
genotype calls. We included sex, leg length, whole body fat, and the first four principal components 
as fixed effects in the LMM used for the ALM GWAS. Sex was included to account for differences 
in muscle mass caused by higher testosterone levels in males40. Testosterone is a potent 
stimulator of muscle growth and if systematically varied in males, it can also influence muscle 
mass (e.g. as a result of hypogonadism41). However, if there was a common genetic basis for such 
variability it could be captured in the association analysis. It needs to be noted that inclusion of sex 
as a covariate would not permit capturing sex-by-locus interactions. Identification of sex specific 
loci, albeit of interest, was not attempted due to complexity posed by the number of genetic 
markers and the sample size. An outcome of a GWAS would also depend of the complexity of 
mechanisms affecting the phenotype and adjustments included in a model9; 42. Leg length and 
whole body fat were included because they are biologically related to muscle mass: longer bones 
result in longer muscles, while fat shares part of its developmental origin with skeletal muscle 
tissue43. Furthermore, each of these traits is correlated with muscle mass. An association was 
considered statistically significant if its P < 5 × 10-8 (α = 0.05). This threshold is the standard for 
GWAS of complex traits44; 45. 
We obtained variance components and SNP heritability estimates of ALM from the middle-
aged cohort using BOLT-REML38. The BOLT-REML method robustly estimates the variance of 
genotyped SNPs and fixed effects on the LMM. As described by Loh et al. 46, BOLT-REML 
partitions the SNP heritability across common alleles; hence, the additive variance is calculated as 
the cumulative variance of genotyped SNPs.  
 
Phenotypic variance explained by ALM loci  
We defined ALM genomic loci using the web-based platform Functional Mapping and Annotation of 
Genome-Wide Association Studies (FUMA GWAS47). A key feature of this tool is the identification 
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of genomic regions and independent genomic signals based on the provided summary statistics of 
a GWAS depending on LD structure; this process is automated using pairwise LD of SNPs in the 
reference panel (1000 genomes project phase 3 EUR 48) previously calculated by PLINK49. We 
provided to FUMA GWAS the summary statistic of our GWAS on ALM with the following 
parameters: 250kb window (maximum distance between LD blocks), r2 > 0.6 (minimum r2 for 
determining LD with independent genome-wide significant SNPs used to determine the limits of 
significant genomic loci), MAF > 0.001 (minimum minor allele frequency to be included in the 
annotation), P < 5 × 10-8 (threshold of significantly associated variants). We refer to the identified 
regions and the independent signals as loci throughout the text. 
We used the top variant (based on the outcome from FUMA47) of each locus identified to 
estimate the proportion of phenotypic variance explained by each locus. We estimated phenotype 
residuals using a model that included the fixed effects and principal components described above. 
We then regressed the residuals on the genotype of the top SNP in a linear model. We estimated 
the coefficients of determination and reported them as the proportion of phenotypic variance 
explained by each locus.  
 
Genetic effects in the elderly cohort 
We tested the combined effect of all 182 genome-wide significant ALM loci identified in the middle-
aged cohort in the elderly cohort using the top SNP at each locus. We used PLINK249 to extract 
genotype dosages for each variant identified in the middle-aged GWAS in the elderly cohort. We 
then estimated a ‘genetic lean mass score’ for each individual using the following procedure. First, 
we estimated the contribution of each variant on the phenotype as a product of the SNP effect size 
obtained from BOLT-LMM (β, calculated based on the reference allele) and the genotype dosage. 
Second, we calculated the ‘lean mass score’ for each individual as the sum of the products for all 
selected variants. We ranked the resulting distribution of lean mass scores in ascending order and 
partitioned it into five quantiles. We used ALM without any adjustment (raw ALM) because 
estimates of effects size already accounted for sex, whole body fat and leg length differences. 
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However, since the raw ALM did not meet the assumption of normality, we used a Kruskal-Wallis 
test (non-parametrical) to evaluate the difference in the median of the phenotypes between the 
quantiles, and a Wilcoxon test (non-parametrical) for pairwise comparisons between quantiles. We 
conducted five replicates of a negative control test that consisted of randomly selecting a subset (n 
~ 185) of non-significant SNPs in the middle-aged cohort and generating ‘lean mass score’ as 
described above for the elderly cohort; this set of SNPs had MAF > 0.001. 
We also aimed to replicate the individual variants effects on the ALM of the elderly cohort. 
We checked normality of ALM in the elderly cohort as described for the middle-aged cohort. We 
tested a subset of genetic variants (n=17,914,406) selected based on their MAF > 0.001 and 
imputation quality > 0.3, and we used the same LMM, fixed covariates, and genome-wide 
significance threshold (P < 5 × 10-8) as described for the middle-aged cohort. We conducted a 
Fisher’s exact test to evaluate if overlapping loci between the middle-aged and elderly cohorts 
were significantly different from random. The null hypothesis was rejected at P < 0.05 (two-tailed). 
 
Genomic regions tagged by loci 
We used the ‘biomaRT’ package in R50; 51 to retrieve gene and regulatory element annotations at 
the genomic position of each statistically significant SNP (P < 5 × 10-8) and Polyphen 252 and 
SIFT53; 54 to predict the functional consequences of each SNP. We retrieved additional information 
about the positional candidate genes and their expression levels from Ensembl55 (release 94 - 
October 2018) and the Genotype Tissue Expression Project (GTEx) portal56 (See Web 
Resources). 
 
Stage two: LGSM AIL mouse cohort and GWAS 
To maximize QTL detection power, we combined three cohorts of LGSM AIL mice from our 
previous reports6; 8; 28 for the second stage of this study (n = 1,867). The LGSM AIL was initiated by 
Dr. James Cheverud at Washington University in St. Louis 57. Cohort 1 included 490 mice (253 
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males and 237 females) from LGSM filial generation 54 (F34). Phenotype data was collected from 
these mice between 80-102 days of age. Cohort 2 consisted of 506 male mice (~ 84 days of age) 
from filial generation 50-54 (F50-54). Cohort 3 includes 887 mice (447 males and 440 females) from 
filial generation 50-56 (F50-56); between 64 - 111 days of age. Mice were housed at room 
temperature (70 - 72°F) at 12:12 h light-dark cycle, with 1-4 same-sex animals per cage and with 
ad libitum access to standard lab chow and water. All procedures were approved by the 
Institutional Animal Care and Use Committee at the University of Chicago (Cohort 1 and 3) and at 
the Pennsylvania State University (Cohort 2). 
 
Mouse traits and genotypes 
We collected muscle phenotypes after the animals were sacrificed and frozen. We dissected four 
muscles and one long bone (tibia or femur) from each mouse at the Pennsylvania State University 
(n = 584) and the University of Aberdeen (n = 1,283). Each of the four muscles exhibits a different 
proportion of muscle fiber types and often revealed muscle specific QTLs6; 7; 20; 28.The dissection 
procedure involved defrosting the carcasses and removing the muscles (TA, EDL, gastrocnemius 
and soleus) and tibia from the hind limbs under a dissection microscope. We weighed the muscles 
to 0.1-mg precision on a Pioneer balance (Pioneer, Ohaus) and measured long bone length of the 
hindlimb (mm) using an electronic digital calliper (Powerfix, Profi). We quantile normalized all 
LGSM AIL traits before mapping QTLs. 
Cohort 1 was genotyped using a custom SNP genotyping array58. These SNPs (n=2,965) 
were evenly distributed along the autosomes (Mus musculus genome assembly MGSCv36 
(mm8)). The median distance between adjacent SNPs was 446 Kb, and the maximum was 18 Mb. 
Large gaps are due to regions identical by descent between the LG/J and SM/J founders59. Cohort 
2 was genotyped at 75,746 SNPs (73,301 on the autosomes and 2,386 on X and Y) using the 
MEGA Mouse Universal Genotyping Array (MegaMUGA; Mus musculus) genome assembly 
MGSCv37 (mm9)); after removing SNP markers that are not polymorphic between the LG/J and 
SM/J strains we retained 7,168 autosomal SNPs for subsequent analyses. The median distance 
between adjacent SNPs was 126.9 Kb and the maximum distance was 15 Mb for all chromosomes 
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except for chromosomes 8, 10, and 14, which had distances of 19, 16, and 16 Mb, respectively. 
We used a conversion tool in Ensembl to convert SNP positions from mm8 and mm9 to Mus 
musculus genome assembly GRCm38 (mm10). Cohort 3 genotypes were obtained from Gonzales 
and colleagues8. These genotypes were generated using genotyping by sequencing. This 
approach has been recently used and described in detail20. Only autosomal SNPs known to be 
polymorphic in the LG/J and SM/J founder strains (n=523,027; mm10, build 38) were retained for 
subsequent analyses. We combined the genotype data from Cohorts 1-3 using PLINK v.1.9 and 
imputed missing genotypes using BEAGLE v.4.160. For these steps, we used a reference panel 
obtained from whole genome sequencing data of the LG/J and SM/J strains59. Dosage estimates 
(expected allele counts) were extracted from the output and used for the GWAS; these estimates 
captured the degree of uncertainty from the imputation procedure. To ensure the quality of the 
genotype data, we excluded SNP genotypes with MAF < 0.20 (because it is an AIL, almost all 
SNPs have MAF > 0.2) and dosage R2 < 0.70 (dosage R2 corresponds the estimated squared 
correlation between the allele dosage and the “true allele dosage” from the genetic marker, and is 
used as a measure of imputation quality). After applying these filters, we retained 434,249 SNPs. 
 
Mouse association analyses 
Population structure can potentially lead to a rise of false positive associations61; 62. The LMM 
approach is used to map QTLs while dealing with confounding effects due to relatedness58; 63; 64. 
We used the LMM method implemented in the software GEMMA (genome-wide efficient mixed-
model association)65 to analyze the mouse phenotypes. In our LMM model we included the 
genotypes, a set of fixed effects described later in this section, and a polygenic effect to deal with 
population structure. 
The polygenic effect is a random vector which was derived from a multivariate normal 
distribution with mean zero and a n × n covariance matrix σ2λK; where n is the number of samples. 
The relatedness matrix K was defined by the genotypes. The two parameters, σ2 and λ, were 
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estimated from the data by GEMMA; they represent the polygenic and residual variance 
components of the phenotypic variance, respectively. 
 
Relatedness matrix and proximal contamination 
We used the genotype data to estimate the relatedness matrix K, which was part of the covariance 
matrix. Although genotype-based and pedigree-based K matrices yield very similar results66; 67, we 
have shown that in general, genotype-based estimates are more accurate66; 68-70. We constructed 
the relatedness matrix as K = XX′/p, where X is the genotype matrix of entries xijand n × p 
dimensions, p is the number of SNPs. 
The relatedness matrix K was estimated taking into account the potential problem of 
proximal contamination67, which involves loss of power due to including genetic markers in multiple 
components of the LMM equation. Furthermore, because of LD, markers in close proximity to the 
genetic marker that is being tested can also lead to deflation of the P values8; 68. To avoid this 
problem, the K matrix was estimated by excluding from the calculations the SNPs within the 
chromosome that was analyzed (this approach is termed leave one chromosome out (LOCO)), 
therefore, K matrix was slightly different for each chromosome.  
 
Genetic and fixed effects 
We did not include non-additive effects in the LMMs used for GWAS in the LGSM AIL. Our 
previous studies6 suggest that musculoskeletal traits in this population are mostly influenced by 
additive loci, and by ignoring dominance effects we avoid introducing an additional degree of 
freedom, hence potentially avoiding a decrease of power to detect QTLs. 
To analyze the muscle weights of the combined data, we used four fixed effects in the 
LMM: sex, dissector of the samples, age, and long bone length of the hindlimb. We selected these 
variables after using a linear model to estimate their effect on the four muscles; only statistically 
significant effects were included (P < 0.01). Sex and dissector were included as binary variables; 
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whereas age and long bone were included as continuous variables. Including long bone length of 
the hindlimb allowed us to capture genetic effects associated with variation in muscle weight per se 
(as opposed to genetic effects on bone length)20. In other words, failing to include long bone as a 
covariate would yield QTLs that are more likely to be genetic contributors to general growth of the 
skeleton instead of specifically muscle. We used two bones for the long bone variable, for cohort 1 
femur, and for cohorts 2 and 3 tibia. Based on personal communication with Dr. Cheverud, the 
femur and tibia bones were found to be positively and highly correlated (r > 0.8) in LGSM AIL 
(F34). We did not include generation (r = 1) and bone type of each cohort (r = 1) as fixed effects 
since the dissector variable functioned as a proxy for these two variables. Body weight was not 




To estimate the SNP heritability or proportion of phenotypic variance explained by all genotypes, 
we used the n × n realized relatedness matrix K, which was constructed using all the available 
genotypes. We extracted the SNP heritability from the QTL mapping outputs of the LGSM AIL 
cohort described before; GEMMA provides an estimate of the heritability and its standard error65. 
The SNPs available to estimate the heritability do not capture all genetic causal variants, hence the 
SNP heritability underestimates the true narrow sense heritability. 
 
Threshold of significance and QTLs intervals 
The P values estimated from the likelihood ratio test statistic performed by GEMMA were 
transformed to –log10 P values. We calculated a threshold to evaluate whether or not a given SNP 
significantly contributes to a QTL. We estimated the distribution of minimum P values under the 
null hypothesis and selected the threshold of significance to be 100(1 –  𝛼)th percentile of this 
distribution, with 𝛼 = 0.05. In order to estimate this distribution, we randomly permuted phenotypes 
1,000 times, as described previously 6; 7; 20; 71. We did not include the relatedness matrix in the 
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permutation tests due to computational restrictions, and because, past studies have found that 
relatedness does not have a major effect on the permutation test6; 7. 
We estimated QTL intervals in three steps. 1) We used Manhattan plots to identify the top 
SNP within each statistically significant region (SNP with highest –log10 P values), which we refer to 
as the peak QTL position. 2) We transformed P values from each analysis to LOD scores (base-10 
logarithm of the likelihood ratio). 3) We applied the LOD interval function implemented in the r/qtl 
package72 to the regions tagged by each peak SNP, and obtained the QTL start and end positions 
based on the 1.5 LOD score interval. 1.5 LOD intervals are commonly used to approximate the ~ 
95% confidence interval of mouse QTLs5; 73. The 1.5 LOD interval estimation is comparable to the 
95% CI in the case of a dense marker map74; hence, its coverage depends on the location of the 
peak QTL marker relative to the adjacent genotyped markers. We estimated the direction of the 
QTL effect by calculating the phenotypic mean of each allele based on the peak SNP of each QTL. 
We adjusted the phenotypic means and standard errors by fitting the fixed effects used in the 
association analyses in a linear model. 
We explored the QTL intervals to identify genes that potentially affect hindlimb muscle 
mass. We retrieved the genomic location of all genes located within the intervals using the BioMart 
database through the ‘biomaRT’ package implemented in R50; 51.  
Meta-analysis in the LGSM AIL mice 
Although we adjusted our GWAS analyses on the LGSM AIL mice for confounding effects, it was 
possible that uncontrolled factors could have affected the phenotypes. Therefore, we conducted an 
additional meta-analysis on the three LGSM AIL cohorts. We first analyzed each cohort separately 
using the same approach as for the combined data, except the dissector variable was not used as 
a covariate because it was largely confounded with the cohort. We extracted P values, estimated 
SNP effects and standard errors at each scanning locus. We considered two popular meta-
analysis approaches: the inverse variance-weighted average and the weighted sum of z-scores75-
77. For weighted sum of z-scores, we tried two weighing schemes, i.e., the sample size and 
squared root of the sample size, and found the results were very similar, and were slightly better 
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than that of the inverse variance-weighted average. Therefore, we chose to report the result of the 
weighted sum of z-scores with the squared root of the sample size being the weight as suggested 
in meta-analysis literature78. The test statistic (𝑍) for each SNP was constructed as follows: 
𝑍 =






where 𝑧𝑖 is the z-score that was obtained by transforming the likelihood ratio test P value and 𝑤𝑖 is 
the squared root of the sample size in cohort 𝑖=1 to 3. We compared this result with the combined 
GWAS of the LGSM AIL. This statistical analysis was performed in R79. 
 
Overlap of mouse and human results 
The significantly associated muscle QTLs (mice) and lean mass loci (humans) were compared by 
exploring the genomic regions and genes tagged in each analysis. We used a Fisher’s exact test to 
evaluate whether the number of overlapping loci from the human and mouse analyses exceeded 
the number expected by chance; the null hypothesis was rejected at P < 0.05. 
 
Gene validation using siRNA in C2C12 myoblasts 
To validate efficiency of siRNA-mediated gene knockdown, the C2C12 cells were lysed and RNA 
isolated using RNeasy mini kit (QIAGEN) following manufacturers recommendations. 
Concentration was assessed using NanoDrop (Thermo Scientific) spectrophotometer and ~1.5 µg 
of RNA was applied to 1.5% agarose gel to validate its integrity. The cDNA was synthesized using 
random primers (Invitrogen) and SuperScript II reverse transcriptase (Invitrogen). Quantitative 
PCR for expression of the target Cpne1, Sbf2 and Stc2 and the reference Actb was carried out in 
duplicates on LightCycler 480 II (Roche) using SYBR green Master mix (Roche), 10 ng cDNA and 
0.5 µM forward and reverse primers (Table S2). Quantification of gene expression was performed 
using the comparative Ct method80. 
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C2C12 myoblasts, validated for differentiation, were seeded on 8-chamber slides (Lab-Tek 
II), batch 1, and 13 mm diameter Thermanox Plastic coverslips (Thermo Fisher Scientific), batch 2, 
at 100 cells/mm2 in high glucose growth medium (D5671, Sigma), containing 10% foetal calf serum 
and 2% glutamine. Next day the cells were washed with phosphate-buffered saline (PBS) and 
transferred to differentiation medium (D5671, Sigma) supplemented with 10 nM siRNA and 
Lipofectamine RNAiMAX (Invitrogen) as per manufacturer protocol. We used the following siRNAs 
(Life Technologies): negative control #1, s113938 and 93494 (Cpne1), 151885 and 151886 (Stc2), 
s115441 and s115442 (Sbf2). The treatment achieved expression knockdown by 55-70%. The 
differentiation medium with 10nM siRNA and Lipofectamine RNAiMAX were replaced once, after 3 
days of incubation. After 6 days of incubation, cells were fixed in 4% paraformaldehyde (PFA). We 
examined 8 cultures for Stc2 and 12 for the remaining genes (equally divided between the two 
siRNAs) and negative control that were generated in two batches on separate occasions. 
Cells were washed in PBS, fixed in 4% PFA for 15 min, PBS washed again and 
permeabilized for 6 min with 0.5% Triton X-100 in PBS. The cells were then blocked for 30 min in 
blocking buffer (10% foetal calf serum in PBS) and incubated overnight at 4 ºC with primary anti-
myosin heavy chains antibody (Monoclonal Anti-Myosin skeletal, Fast, Clone My-32, Mouse 
Ascities Fluid, M4276, Sigma-Aldrich) diluted (1:400) in PBS. After three washes in 0.025% 
Tween-20 in PBS at room temperature, secondary donkey anti-mouse IgG H&L antibody 
(ab150109, abcam) conjugated to fluorescent dye (Alexa Fluor 488) in PBS (1:400) were applied 
and incubated for 90 minutes. Following three washes in 0.025% Tween-20 in PBS cells were 
incubated in 300 nM DAPI in PBS for 15 min. After that cells were covered by coverslip using 
Mowiol 4-88 (Sigma-Aldrich), sealed with nail polish, and stored at 4 C in the dark. 
Slides were scanned using Axioscan Z1 slide scanner (Zeiss) using X20 magnification. The 
entire 0.7 cm2 chamber of a slide or a coverslip was imaged using the wavelength spectrum band 
of 353-465 nm and 493-517 nm and exposure time 4 ms and 100 ms for DAPI and Alexa Fluor, 
respectively, at 50% Colibri 7 UV-free LED light source intensity. Alexa Fluor and DAPI channel 
images of a rectangular area free of artefacts and covering at 14-91% of a chamber of batch 1 and 
70% of a coverslip of batch 2 were exported separately for analyses with Fiji81. Note that the 
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rectangle area of the majority of batch 1 samples (88%), covered more than 40% of the cell 
culture. A sensitivity analysis testing the exclusion of small coverage images (14-31%) from the 
statistical analyses described below, showed results comparable to the analysis of all samples; 
therefore, we reported significance values (P values) corresponding to the statistical analysis of all 
samples. 
Three indices characterizing the effect of treatment on myogenesis were quantified in an 
unbiased, automated analysis of the entire exported area: 1) percentage of fluorescent area in the 
Alexa Fluor channel, reflecting the level of myosin expression, and 2) the longest-shortest-path 
reflecting the length and number of myotubes (Figure S2). The longest-shortest-path analysis was 
carried out using the Analyze Skeleton plugin82 and the shortest path calculation function83 
implemented in Fiji81. We carried out the image analyses on a Linux computer and we allocated 
190 GB of RAM for these analyses. The myotube threshold was set at 103.97 µm for batch 1 and 
191.63 µm for batch 2, i.e. the mean (batch 1: 54.34 µm, batch 2:100.95 µm) plus 3 standard 
deviations (batch 1: SD = 16.54 µm, batch 2: SD = 30.23 µm) of the length of mononucleated and 
myosin expressing myocytes (n=35) measured in the negative control #1 cells. The myotube 
length variable did not follow normality, therefore quantile normalization was applied to the 
variable. All statistical analyses were adjusted for the image area of each sample and batch of 
cells, by fitting a linear model on the three indices investigated; all subsequent statistical analyses 
were conducted on the residuals, which met the assumptions of normality and homoscedasticity of 
residuals. The effect of gene knockdown on these indices was assessed using ANOVA. After, a t-
test was carried out to evaluate the mean differences between the control group and the gene 
knockdown groups. In addition, we evaluated the myosin expressing area (as percentage of the 
total) present within each knockdown versus control groups using ANOVA. 
 
Data availability 
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The human data used for this study can be obtained upon application to the UK biobank project16. 
LGSM AIL genotypes (dosages) and phenotypes (raw) are freely and publicly available on 




Over 180 genomic loci associated with appendicular lean mass in humans 
The appendicular lean mass (ALM) ranged from 12.2 to 41.6 kg and 15.3 to 54.5 kg in healthy 
middle age females and males, respectively (Table 1). SNP heritability estimates indicated that 
36% of phenotypic variability was due to genetic factors. The GWAS analysis results presented in 
Figure 1 revealed 6,693 autosomal variants (MAF > 0.001) associated (P < 5 x 10-8) with ALM 
(Table S3). The associated variants tagged 331 genes and 753 regulatory elements. We used the 
Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA GWAS47) to 
define genomic regions containing the associated variants, and we identified 77 of them that were 
on average 0.40 Mb long and contained 182 independent signals (Table S4). We refer to the 
identified regions and the independent signals as “loci” throughout the text. The 182 loci identified 
indicate that ALM is influenced by multiple genetic elements. The LD score intercept that we 
estimated during this ALM GWAS (1.05  0.007 (mean  SE)) provides further evidence 
suggesting polygenicity. Cumulative effects of these loci explained 24% of SNP heritability.  
 
78% of the same loci affect appendicular lean mass in older adults  
As expected due to the aging effect on skeletal muscle, the ALM in the cohort of elderly declined 
by 4 and 8% in comparison to the middle-age cohort of females and males, respectively (P < 2×10-
16). A more prominent decline in males is consistent with earlier reports84. We then used a ‘genetic 
lean mass score’ (see Methods for details) to test if the identified 182 loci contributed to ALM 
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variability in the elderly population. The genetic lean mass score had a statistically significant 
overall effect (χ2 = 376.13, df = 4, P = 3.99×10-80) on ALM variability in the elderly population 
(Figure 2). On average, individuals with the highest genetic lean mass score had 0.73 kg, or 3.2%, 
more ALM compared to those with the lowest scores (Figure 2). Negative controls showed no 
statistically significant effects (Table S5 and Figure S3). 
We also asked if the variants identified in the middle-aged cohort were associated with ALM 
in the elderly. A GWAS in the elderly cohort replicated 5,291 variants based on their P value (P < 5 
× 10-8) and allelic effect (beta); moreover, the replicated variants tagged 78% of the ALM loci of the 
middle-aged cohort (two tailed Fisher test P value < 2.2  10-16). Overall, the set of genomic loci in 
the elderly cohort appeared similar to that of the middle-aged adults, with the exception of an 
approximately 5 Mb region on chromosome 5 (Figure S4). This region showed a very strong 
association with the ALM variability in older adults (lowest P value = 4.50  10-56, beta = 0.12 ± 
0.01 kg), and had a modest albeit significant association with the ALM of middle-aged individuals 
(lowest P value = 3.30  10-11) with an effect size of 0.07 ± 0.01 kg. 
 
23 QTLs contribute to muscle weight variability in LG/J and SM/J strain-
derived advanced intercross lines  
We examined the weight of four hindlimb muscles of the LGSM AIL (F34 and F50-F56): tibialis 
anterior (TA), extensor digitorium longus (EDL), gastrocnemius and soleus. The LGSM AIL 
muscles showed extensive individual variability (Table 2); furthermore, the SNP heritabilities of the 
TA, EDL, gastrocnemius and soleus muscles were 0.39, 0.42, 0.31 and 0.30, respectively (Table 
2). The genome mapping of LGSM AIL muscles yielded 23 QTLs (P < 6.45 × 10-06). The TA, EDL 
and gastrocnemius QTLs explained more than the 50% of the SNP heritability of each trait (Table 
S6). The soleus muscle phenotypic variability explained by QTLs was 23% of its SNP heritability. 
Three QTLs were shared between the four hindlimb muscles (chromosome 7, 11 and 13; (Figure 
3); the QTL on chromosome 13 resulted in the strongest association (EDL P = 2.95 × 10-21), with 
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its peak position at 104,435,003 bp, and the percentage of phenotypic variance explained by this 
locus was 5.2%; the SM/J allele conferred increased muscle mass (Figure 3). Furthermore, six 
QTLs were shared between two or three hindlimb muscles, while fourteen identified QTLs were 
only associated with one specific hindlimb muscle (Figure 3). 
The mapping resolution was comparable to that attained in the previous study in the LGSM 
AIL cohort8. On average, mouse QTLs spanned 2.80 Mb (based on the 1.5 LOD interval) and 
encompassed 2,267 known genes (Table S7). The median number of genes per QTL was 55; 
more than half of the mouse QTLs contained a modest number of genes; however, 7 QTLs 
contained more than 100 genes each, and a single QTL located on chromosome 7 as many as 644 
genes (Table S6). Although all mouse QTLs identified in the LGSM AIL contained SNPs, at least 
seven QTLs covered long genomic regions characterized as identical by descent between the LG/J 
and SM/J strains59. We also analyzed the LGSM AIL using a meta-analysis approach and identified 
14 QTLs that on average were 3.78 Mb long. The majority of the QTLs from the meta-analysis, 12 
out of the 14, overlapped with the findings of the mega-analysis (Figure S5). The meta-analysis 
results are shown in Table S8. 
 
Interspecies overlap between appendicular lean mass loci and muscle weight 
QTLs  
The ALM mainly consists of the skeletal muscle of the extremities; however, other tissues also 
contribute. To test the hypothesis that ALM-associated genetic variants primarily affect skeletal 
muscle mass, we overlaid human ALM finding with the mouse where skeletal muscle was weighed 
directly. Specifically, we overlaid the captured genomic regions restricted by the significant SNPs 
used in the GWAS of each species. The mouse QTL regions were notably larger, partially due to 
the median distance between adjacent genetic markers of 126.9 Kb. Our analysis identified five 
syntenic regions associated with ALM in humans and hindlimb muscle mass in mice (Table 3). We 
used Fisher’s exact test to discover that the number of overlapping regions significantly (P = 
0.0019; Table S9) exceeded that which could be expected by chance. This analysis permitted us to 
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shorten the list of positional candidates. Assuming the same causative entity for an overlapping 
mouse and human locus, these five loci harbour 38 homologous genes (Table 3). Encouragingly, 
four of these five genomic loci tagged by rs148833559, rs9469775, rs4837613 and rs57153895 
SNPs (Table S3) were replicated in the ALM of the elderly cohort (Table S10). 
 
Modifiers of in vitro myogenesis 
We used siRNA-mediated gene knockdown in C2C12 cells to test if candidate genes affected 
myogenic differentiation. The STC285, CPNE15 and SBF286 were prioritized for this assay because 
they were highlighted by both mouse and human GWAS. We assessed indices of myogenic 
differentiation (the number and length of the myotubes, and expression of myosin) of C2C12 cells. 
In total, 34,989 myotubes were identified and measured in 44 cell cultures (see Methods for 
details). The gene knockdown had a significant effect on myotube length, with Cpne1 (P = 0.001, 
95% confidence interval = 0.019-0.068, effect size = 0.024) and Stc2 (P = 0.015, 95% confidence 
interval= 0.007-0.066, effect size = 0.017) showing an increase in length compared to the control 
cells (Figure 4). There was no significant difference for the Sbf2 gene. The pattern of the effect on 
myosin expressing area was similar to that of myotube length but was not statistically significant (P 
= 0.21). The number of myotubes was also unaffected. 
 
Discussion 
The key findings of the present report are as follows: 1) we identified a set of over 180 loci 
associated with ALM, a substantial expansion in comparison to previous human studies. 2) There 
is a substantial overlap of the genetic effects between middle-aged and elderly subjects. 3) 
Integration of mouse and human GWAS indicates that skeletal muscle is the primary component 
affected by the ALM loci, facilitates prioritization of candidate genes, and helps prediction of their 
effect on cellular mechanisms underlying muscle mass variation. 4) In vitro studies validated two 
genes, CPNE1 and STC2, as modifiers of muscle mass in humans. 
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We estimated SNP heritability for ALM to be of 0.36, which is lower than heritability 
estimates previously reported (0.44) 9, this difference could be due to different fixed effects used to 
estimate variance components. In total, we mapped 182 loci that collectively explain 24% of the 
SNP heritability of ALM. The most recent report, a meta-analysis of 47 independent cohorts 
(dbGAP), comparable in sample size but ranging in subjects aged 18 to 100 years, reported five 
significant associations with lean body mass9. Even fewer associations were detected in the 
earlier, small sample size studies11; 13-15; 87. However, our results indicate that ALM is a highly 
polygenic trait in humans. We hypothesize that multiple factors contributed to the improved locus 
detection in the present GWAS. We restricted subjects’ age to a narrow range, 38 to 49 years, 
minimizing the effects of the developmental and aging-related processes on phenotypic variance. 
The skeletal muscle is a dynamic tissue reaching its peak mass by late 20s, then a trend of decline 
emerges after 40s and accelerates about two decades later1. An estimated 30-50% decline in 
muscle mass can be expected between 40 and 80 years of age88. These developmental and 
aging-related changes are not linear in progression and therefore would hamper detection of loci 
even if accounted for in a linear model. In addition, unlike Zillikens and colleagues9, the data set 
we used was systematically collected as described by the UK Biobank project16 and we only 
employed bioelectric impedance measurements of lean mass. Furthermore, we used a LMM to test 
the effects of > 21 million variants (MAF > 0.001), and our analysis was adjusted for a different set 
of fixed effects than in previous research9; 11; 13; 15. Our analysis captured three loci identified by 
Zillikens and colleagues9, containing the VCAM, ADAMTSL3 and FTO genes, suggesting that their 
effects are not influenced by age. We hypothesize that a combination of a homogeneous age 
group, the optimized genomic coverage and the method used to conduct this association analysis 
contributed to improved detection of loci in the present study. 
The analyses presented here shed light into the complex genetic mechanisms behind the 
appendicular muscle mass of humans. In the past, concern was expressed about the 
reproducibility of association analyses of complex traits; however, an increasing number of human 
GWAS have shown that their findings are remarkably reproducible89. The present study provides 
further support for the reliability of association studies, demonstrating replication of 78% of ALM 
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loci in the elderly cohort. Furthermore, we show that the genetic profile characterized by depletion 
of ALM-increasing alleles leads to a lower ALM in elderly individuals (Figure 2). Hence, it is 
conceivable that genetic architecture predisposing individuals to lower muscle mass may lead to 
elevated risk of sarcopenia1. 
Combining two experimental models, mouse and human, facilitated prioritization of 
candidate genes for functional validation and indicated that skeletal muscle is the primary 
component of lean tissues affected by the identified loci. Furthermore, the mouse model revealed 
that genetic effects may not all be uniform across skeletal muscle tissue, instead some of the 
effects can be muscle type- or muscle-specific. To establish the association between the QTGs of 
the identified loci and the muscular phenotype, we focused on the overlapping human and mouse 
results. Integration of results from these two species permitted circumvention of the limitations 
imposed by the individual models. While human GWAS often identify loci containing single genes, 
it is often unclear which tissue is most relevant to the phenotype. Although mouse QTLs often 
contain multiple positional candidate genes, mice can be used as experimental models to identify 
loci specifically associated with skeletal muscle. In this study, we used a mouse model to show that 
the association with hindlimb skeletal muscle mass was specifically related to differences in the 
cross-sectional area of the constituent muscle fibers, rather than to the number of fibers in the 
muscle. This is because between the two founders of the LGSM AIL, the LG/J strain compared to 
the SM/J strain shows over 50% larger cross-sectional area of muscle fibers, but no difference in 
the number of fibers in soleus muscle22. Hence, it is conceivable that the QTGs of the majority of 
the overlapping loci affected hindlimb muscle mass specifically via the hypertrophy of muscle 
fibers. Such prioritization between the two cellular mechanisms of muscle mass variability is 
important because genes specifically influencing cross-sectional area of muscle fibers can be 
targeted pharmacologically to prevent and reverse atrophy of muscle fibers in aging muscle90. In 
humans, the bone, muscle and skin tissues contribute to lean mass determined by bioelectric 
impedance. Approximately 1-2 mm thick skin91 constitutes a rather minor component of lean mass 
compared to the size of human extremities. The long bones determine axial dimensions of a limb 
but we adjusted for that to minimize bone effect on variation of lean mass. Whereas the magnetic 
    25 
 
resonance imaging (MRI) assessed muscle mass accounts for ~38% of body weight in humans, 
and the MRI data strongly and positively correlates with the estimates of bioelectric impedance92. 
This, collectively with the overlap of the ALM loci and mouse muscle QTLs, provides a strong 
support for the notion that skeletal muscle is the primary tissue affected by the ALM loci. 
For the functional validation we prioritized three candidate genes (STC2, SBF2 and 
CPNE1) implicated by both human and mouse analyses. STC2 had the largest effect size on the 
ALM (beta = 0.88 ± 0.13 kg; Table S3) with the minor allele (A) of a missense SNP (rs148833559 
(A/C) associated with the increase in ALM. Prediction tools (SIFT54, PolyPhen52, CADD93, and 
REVEL94) suggested a detrimental consequence of rs148833559 on STC2 structure. SBF2 has 
been linked to Charcot-Marie-Tooth hereditary motor and sensory neuropathy86, and is expressed 
in skeletal muscle and associated with a cis-eQTL56. Although little is known about CPNE1, it is an 
intriguing candidate because the minor allele of the missense variant (rs12481228) is predicted by 
SIFT54 and PolyPhen53 to be detrimental on the structure of CPNE1. That allele was associated 
with increased ALM in the middle-aged cohort, and a frameshift variant (rs147019139) leading to 
premature stop codon was also associated with an increase in ALM in the elderly cohort (Table 
S10). Furthermore, in a previous GWAS using outbred (CFW) mice5, Cpne1 was implicated in 
hindlimb muscle mass. To validate these QTGs for their effects on skeletal muscle, we tested the 
siRNA-mediated knockdown effect on myogenesis in vitro. A knockdown of two genes, CPNE1 and 
STC2, increased the length of the myotubes. Although it is not completely understood how 
changes in the indices of in vitro myogenesis correlate with the fiber hypertrophy and/or 
hyperplasia in vivo, our findings implicate an upregulation of myogenic differentiation. We interpret 
this in vitro observation as being consistent with the allelic effect of the two loci identified in human 
GWAS. CPNE1 encodes for Copine 1, a soluble calcium-dependent membrane-binding protein95 
expressed in skeletal muscle25. STC2 encodes Stanniocalcin 2, a homodimeric glycoprotein 
hormone abundantly expressed in skeletal56 and cardiac muscle96, and involved in regulation of 
IGF1 through interaction with pregnancy-associated plasma protein-A97. A suppressive role of 
STC2 is consistent with reduced muscle mass in the STC2 overexpressing mice85. Hence, our 
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analyses and recent reports provide support for CPNE1 and STC2 as suppressors of muscle mass 
development and/or maintenance in humans. 
In conclusion, the present study integrated human and mouse GWAS and used in vitro 
validation to further interrogate a subset of the genes implicated in both species. Our results 
revealed over 180 genomic loci contributing to ALM in middle-aged humans. The effects of the 
majority of these loci persist in the elderly human population. Integration of human and mouse data 
also highlighted candidate genes affecting skeletal muscle mass in mammals. Two genes, CPNE1 
and STC2 were confirmed to be modifiers of in vitro myogenesis. 
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Figure 1. Map of genome associations with the appendicular lean mass (ALM) of humans. 
Genome-wide association study (GWAS) on the ALM of middle-aged adults from the UK Biobank. 
Significance level is presented on the vertical axis, while the chromosomal position of each genetic 
marker is shown on the horizontal axis. Red line across the plot represents the genome-wide 
threshold of significance (P < 5 x 10-8). This plot shows the association of variants with MAF > 
0.001.  
 
Figure 2. Genetic lean mass score affects the appendicular lean mass (ALM) in elderly humans. 
The plot shows the ALM (kg) of the elderly cohort on the vertical axis. The elderly cohort was 
ranked by genetic lean mass score and clustered in five quantiles (Q1 to Q5) (horizontal axis). The 
average genetic lean mass score ( standard error) of each quantile is shown in parenthesis below 
the horizontal axis. The overall quantile effect of the genetic lean mass score on ALM was tested 
with Kruskal-Wallis test and the resulting P value is presented on the top of horizontal line above 
the bars. The ALM median differences between the groups were tested using a Wilcoxon test; the 
significance level of each comparison is presented above the horizontal lines with a Holm adjusted 
P value. 
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Figure 3. Muscle weight QTLs identified in mice of the LGSM AIL and density plot of the 
genotypes. The circle plot (A) shows from the outer to the inner ring the GWAS of the TA, EDL, 
gastrocnemius and soleus muscle weights. Chromosomal position of each SNP is shown in the 
outer black circle of the plot; chromosome names are shown outside as “Chr”. Dots within each 
chromosome space represent the association (–log10 P value) of each SNP tested. Dotted blue 
lines represent the genome-wide threshold (P < 6.45 × 10-06) of significance, and red dots above 
the genome-wide threshold are significantly associated SNPs. (B) Plots of the allelic effect of the 
Skmw34, Skmw55 and Skmw46 QTLs on the EDL muscle mass. These QTLs were identified for 
the four muscles investigated. Vertical axis represents the residual muscle mass adjusted for sex, 
age, dissector and long bone length of the hindlimb, and the horizontal axis shows the genotypes 
(LG/J homozygote, heterozygote and SM/J homozygote). Below the horizontal axis, the number of 
individuals with a given genotype is provided. The violin shapes within the plot area represent the 
distribution of individuals with the genotypes. Box whiskers represent minimum and maximum 
values, distance between a whisker and the top or bottom of the box contains 25% of the 
distribution, the box captures 50% of the distribution, and the bold horizontal line represents the 
median. Pairwise comparison P value (t-test) is shown above horizontal lines at the top of the 
plots.  
 
Figure 4. Gene knockdown effect on C2C12 myotube length. 
This figure shows the gene knockdown effect of the Cpne1, Sbf2 and Stc2 genes on myotube 
length. The overall effect of the gene knockdown on myotube length was tested using ANOVA and 
the resulting P value was 0.00017 (F3, 34985 =6.63). Vertical axis represents the myotube length 
(quantile normalised) residuals (adjusted for area analyzed and batch of cells), and the horizontal 
axis shows control and knockdown gene groups. Boxes represent the distribution of the myotube 
length for each group. Box whiskers represent minimum and maximum values within 1.5-fold 
interquartile range above the 75th percentile and below the 25th percentile; the box captures 50% of 
the distribution, and the bold horizontal line represents the median value of the myotube length 
normalized residuals distribution for each knockdown group. Each red dot represents a single cell 
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culture sample for each knockdown group. Statistically significant t–test P values between control 
and knockdown genes are presented above horizontal lines. Effects without a statistically 
significant difference between the control and gene knockdown are presented as “ns”. Cpne1 and 
Stc2 knockdown groups were not different from each other (P > 0.05). Sbf2 knockdown differed 
from Cpne1 (P = 0.002) and Stc2 (P = 0.043). 
 
Tables 
Table 1. Summary of the middle-aged cohort 
Trait N MIN MAX AVERAGE SD SNP heritability ± SE 
Age (years) 
Females =  46,353 39.67 49.00 44.98 2.43 
n/a 
Males = 39,397 38.83 49.00 44.89 2.46 
ALM (kg) 
Females =  46,307 12.20 41.60 20.05 2.57 
0.36 ± 0.003 
Males = 39,353 15.30 54.50 30.17 3.95 
Arm lean mass (kg) 
Females =  46,314 1.00 5.10 2.29 0.31 
0.32 ± 0.003 
Males =  39,362 1.60 7.10 3.85 0.57 
Leg lean mass (kg) 
Females =  46,323 4.60 16.60 7.77 0.98 
0.36 ± 0.003 
Males =  39,373 6.20 20.00 11.31 1.42 
WBF (kg) 
Females =  46,308 5.00 109.80 25.54 10.63 
0.33 ± 0.006 
Males =  39,171 5.00 88.50 21.12 8.29 
Leg (cm) Females =  46,302 43.00 113.00 76.57 4.27 
0.59 ± 0.010 
  Males =  39,353 40.00 122.00 83.87 4.68 
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Column description from left to right: 1) Trait, 2) Number of records, 3) Minimum value within the 
distribution of each trait, 4) Maximum value within the distribution of each trait, 5) Average value of 
each trait, 6) Standard deviation, 7) SNP heritability of the ALM across sex. All summary statistic 
values were calculated for each sex group. ALM: appendicular lean mass. WBF: whole body fat. n/a: 
no applicable. 
 
Table 2. Summary of the LGSM AIL muscle traits 
Trait N MIN MAX AVERAGE SD SNP heritability ± SE 
Tibialis anterior (mg) Females =    675 26.60 57.20 42.22 5.34 0.39 ± 0.03 
Males     = 1,186 31.60 70.80 50.11 6.73 
Extensor digitorum 
longus (mg) 
Females =    675 4.60 10.40 7.52 0.94 0.42 ± 0.03 
Males     = 1,184 5.90 13.30 9.31 1.30 
Gastrocnemius (mg) Females =    675 64.00 133.00 93.15 10.68 0.31 ± 0.03 
Males     = 1,187 70.20 174.90 119.32 16.32 
Soleus (mg) Females =    671 3.20 10.30 6.34 1.18 0.30 ± 0.03 
Males     = 1,187 4.00 13.50 7.78 1.64 
Column description from left to right: 1) Trait, 2) Number of records, 3) Minimum value within the 
distribution of each trait, 4) Maximum value within the distribution of each trait, 5) Average or mean 
value of each trait distribution, 6) Standard deviation of the mean, 7) SNP heritability for each trait 
across sex. Summary statistic values were calculated for each sex group.  
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Gene symbol Human gene name Differential 
expression in 
mouse Soleus 
5:64555615 13:104435003 NS ADAMTS6 ADAM 
metallopeptidase with 
thrombospondin type 1 
motif 6  
0.44 
5:172755066 11:31680504 5.6 × 10-11 STC2 stanniocalcin 2  0.97 
6:34335091 17:34968724 7.1 × 10-09 HLA-B major 
histocompatibility 
complex, class I, B  
0.77 
   
HLA-DQB1 major 
histocompatibility 
complex, class II, DQ 
beta 1  
0.76 
   
BTNL2 butyrophilin like 2  n/a    
TSBP1 testis expressed basic 
protein 1  
n/a 
   
PBX2 PBX homeobox 2  n/a    
ATF6B activating transcription 
factor 6 beta  
0.74 
   
TNXB tenascin XB  0.63    
C4B complement C4B 
(Chido blood group)  
0.37 
   
STK19 serine/threonine kinase 
19  
0.43 
   
SKIV2L Ski2 like RNA helicase  0.83    
NELFE negative elongation 
factor complex 
member E  
n/a 
   
AL645922.1 novel complement 
component 2 (C2) and 
complement factor B 
(CFB) protein 
0.99 
   
C2 complement C2  0.43    
EHMT2 euchromatic histone 
lysine 
methyltransferase 2  
0.78 
   
SLC44A4 solute carrier family 44 
member 4  
n/a 
   
NEU1 neuraminidase 1  0.15    
HSPA1L heat shock protein 
family A (Hsp70) 
member 1 like  
0.04 
   
LSM2 LSM2 homolog, U6 




   
VARS valyl-tRNA synthetase  0.95    
VWA7 von Willebrand factor A 
domain containing 7  
n/a 
   
MSH5 mutS homolog 5  n/a    
CLIC1 chloride intracellular 
channel 1  
0.48 
   
AL662899.1 novel transcript n/a    
ABHD16A abhydrolase domain 
containing 16A  
0.95 
   
AL662899.2 novel protein n/a    
CSNK2B casein kinase 2 beta  0.43    
GPANK1 G-patch domain and 
ankyrin repeats 1  
0.02 
   
APOM apolipoprotein M  n/a    
BAG6 BCL2 associated 
athanogene 6  
0.86 
   
PRRC2A proline rich coiled-coil 
2A  
0.5 
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ATP6V1G2 ATPase H+ 
transporting V1 subunit 
G2  
0.88 
   
DDX39B DExD-box helicase 
39B  
0.46 
9:119309525 4:65416188 1.2 × 10-08 ASTN2 astrotactin 2  0.01 
11:10322720 7:109218379 6.6 × 10-17 SBF2 SET binding factor 2  0.76    
ADM adrenomedullin  n/a 
      AMPD3 adenosine 
monophosphate 
deaminase 3  
0.06 
Column description from left to right: 1) ALM Human locus peak position as “chromosome: base 
pair position”, 2) LGSM QTL peak position as “chromosome: base pair position” (syntenic to 
human), 3) Elderly cohort P value (NS – not significant), 4) Human gene symbol, 5) Human gene 
name, 6) Adjusted P value of differential expression between the soleus muscle of the LG/J and 
SM/J mouse strains25. 
 
